Trelleborg to Present Sustained-Release Drug Delivery Solutions at Formulation & Delivery 2024
![Drug-Eluting-Implant_1](/medical/-/media/tss-media-repository/healthcare-and-medical/banners/products-and-capabilities/combination-products/drug-eluting-implant_1.jpg?rev=8245c5ad07894246b23d1b95cb603f5b&w=800&hash=81F1EE531E6218785EA9B6776E9B6BB4)
Trelleborg Medical Solutions will present a session titled “Sustained-Release Drug Delivery - Drug, Polymer & Manufacturing Process Selection” at Oxford Global’s Formulation & Delivery 2024 Congress, which takes place April 25-26 in London, UK.
Zach Fletcher, Business Development Manager, Drug Delivery at Trelleborg Medical Solutions will present an overview of the process of selecting drug, polymer and manufacturing process for sustained-release implantable drug delivery systems.
The event will see 400+ leaders, experts and researchers from pharmaceutical and biotech organizations, as well as academia, gather for high-level discussions on the latest innovations in pharmaceutical drug formulation, drug delivery, inhaled therapeutics and ribonucleic acid (RNA) development.